• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»This new HIV therapy could boost immunity levels in patients

This new HIV therapy could boost immunity levels in patients

Loknath Das 18 Aug 2018 Health Comments Off on This new HIV therapy could boost immunity levels in patients 348 Views

HIV,HIV treatment,HIV and immunity

Turns out, a new HIV drug can reduce the viral replication and increase immune cells in individuals with advanced, drug-resistant HIV infection.

Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers at Yale University said.

For some individuals with HIV, existing drug therapies fail to suppress the virus, leading to drug resistance and worsening disease. While several HIV drugs target the virus effectively, there has not been a new class of HIV drugs approved to combat the disease in a decade.

During the study, patients received a dose of ibalizumab, which is delivered intravenously, in addition to their failing regimen, for one week. After that period, they received ibalizumab in combination with optimized treatment regimens for six months.

The research team found that after one week on ibalizumab, the majority of the 40 patients (83%) enrolled in the study experienced a decrease in viral load, which refers to the amount of HIV detected in the blood. After 25 weeks, nearly half of patients saw viral load suppression dip below the level of detection. The researchers also reported an increase in CD4 T cells, which are a marker for immune strength. A single individual experienced an adverse event, which was felt to be ibalizumab-related and resulted in withdrawal from the study, the researchers said.

As the first monoclonal antibody approved to treat HIV, ibalizumab is a promising option for individuals who have tried several other drug therapies.

Because of its novel mechanism, ibalizumab will not interact negatively with other medications. It is also delivered intravenously every two weeks and lasts longer than current HIV drugs, which are taken daily by mouth.

The findings appeared in the New England Journal of Medicine.

[“source=hindustantimes”]

boost could HIV Immunity in levels New patients therapy this 2018-08-18
Tags boost could HIV Immunity in levels New patients therapy this
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Loknath Das
Previous Article :

Smokers better off quitting, even with the risk of weight gain

Next Article :

Car Subscription – Freedom, Mobility and Savings

Related Articles

Quitting vaping: the health reasons why you should give up vaping

Quitting vaping: the health reasons why you should give up vaping

admin 30 Jul 2025
Acidity Problems?  21 Home Remedies That Can Be Beneficial

Acidity Problems? 21 Home Remedies That Can Be Beneficial

admin 06 Jun 2025
MyChart: 8 Things You May Not Know You Can Do

MyChart: 8 Things You May Not Know You Can Do

admin 12 Mar 2025

Latest Post

Gaming Your Way to Sharper AI Prompts
Technology

Gaming Your Way to Sharper AI Prompts

admin 07 Aug 2025
15 Elegant Living Room Hanging Lights
Home Deco

15 Elegant Living Room Hanging Lights

admin 04 Aug 2025
115 Ideas for Real Estate Blogs: How to Make the Most of Your Online Presence and Get Leads
Real Estate

115 Ideas for Real Estate Blogs: How to Make the Most of Your Online Presence and Get Leads

admin 02 Aug 2025
Quitting vaping: the health reasons why you should give up vaping
Health

Quitting vaping: the health reasons why you should give up vaping

admin 30 Jul 2025
5 tips for getting started with Flow
Uncategorized

5 tips for getting started with Flow

admin 26 Jun 2025
Acidity Problems?  21 Home Remedies That Can Be Beneficial
Health

Acidity Problems? 21 Home Remedies That Can Be Beneficial

admin 06 Jun 2025
Cross-skilling: How to maintain government efficiency amidst change
Technology

Cross-skilling: How to maintain government efficiency amidst change

admin 21 May 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme